Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium.

Psychopharmacology
F ArtigasC Udina

Abstract

The effect of lithium salts administered chronically to bipolar patients on peripheral measures of the serotoninergic system has been studied. Plasma free serotonin (5HT), whole blood 5HT, plasma 5-hydroxyindoleacetic acid (5HIAA) and plasma total tryptophan (TP) have been analyzed in 22 patients treated with lithium carbonate (mean daily dose: 1280 mg, mean serum concentration: 0.73 mmol/l) and compared to 14 healthy controls and 11 patients treated chronically with antipsychotic drugs. Lithium salts induced significant increases in plasma free 5HT (+159% with respect to control values) and in plasma 5HIAA (+39%) without affecting 5HT contained in platelets. Plasma TP was also unchanged by chronic lithium treatment. The ratio between 5HT stored in platelets and 5HT free in plasma, a variable reduced after uptake inhibitors like clomipramine, was decreased in lithium-treated patients (-50%). These results are compatible with an enhanced synthesis of 5HT in the periphery (mainly enterochromaffin cells) as well as with an inhibition of platelet 5HT uptake (or increased 5HT efflux from intracellular stores) induced by lithium. The lack of effect of several antipsychotic drugs upon these variables is consistent with their predomina...Continue Reading

References

Jan 1, 1988·Life Sciences·J OrtizE Gelpí
Aug 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·H SchwörerH Kilbinger
Jul 1, 1986·Neurochemical Research·I J WajdaA Lajtha
Nov 1, 1986·Acta Psychiatrica Scandinavica·R BalonR B Pohl
Jan 1, 1988·Psychopharmacology·H Y Wang, E Friedman
Mar 25, 1988·JAMA : the Journal of the American Medical Association·M Schou
Aug 1, 1987·The Journal of Surgical Research·J F KuemmerleJ M Kellum
Aug 1, 1988·Biological Psychiatry·E H CookD X Freedman
Dec 1, 1987·Biological Psychiatry·M J SarriasM Casas
Mar 1, 1987·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·O NilssonL E Ericson
Mar 1, 1985·Pharmacopsychiatry·B Müller-Oerlinghausen
Jul 1, 1971·Journal of Neurochemistry·A TagliamonteG L Gessa
Sep 15, 1971·Experientia·A PletscherJ P Tranzer
Sep 1, 1970·The American Journal of Psychiatry·D L MurphyW E Bunney
Jan 1, 1980·Annual Review of Neuroscience·R J Baldessarini, D Tarsy
Oct 1, 1983·Journal of the Autonomic Nervous System·H Ahlman, A Dahlström
Jun 1, 1984·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R D Dey, J Hoffpauir
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·R C AroraH Y Meltzer
Jan 1, 1982·Annual Review of Physiology·C N Gillis, B R Pitt
Mar 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·C Dé MontignyJ P Deschenes
Apr 1, 1980·British Journal of Clinical Pharmacology·G V BornK Martin
Mar 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·A CoppenK Wood

❮ Previous
Next ❯

Citations

Mar 23, 2002·European Journal of Pharmacology·Alessandro SerrettiEnrico Smeraldi
Apr 12, 2000·Journal of Psychiatric Research·A SerrettiE Smeraldi
Sep 30, 1999·Journal of Psychiatric Research·A SerrettiE Smeraldi
Feb 1, 1997·Journal of Affective Disorders·E AlvarezR Noguera
Jan 19, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·X Páez, L Hernández
Dec 18, 2008·Experimental and Clinical Psychopharmacology·Richard B RothmanMichael H Baumann
Mar 27, 2002·The Pharmacogenomics Journal·A SerrettiE Smeraldi
Apr 9, 2009·American Journal of Therapeutics·Richard B Rothman
Feb 4, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Alessandro Serretti, Paola Artioli
Sep 5, 2001·Journal of Affective Disorders·T Mahmood, T Silverstone
Jun 10, 2009·Expert Opinion on Drug Safety·Richard B Rothman, Michael H Baumann
May 20, 2008·International Immunopharmacology·L M LoebH B Nader
Nov 11, 2008·Annals of the New York Academy of Sciences·Richard B RothmanMichael H Baumann
Sep 6, 2008·Progress in Brain Research·Richard B RothmanMichael H Baumann
Aug 9, 2013·Journal of Psychopharmacology·Shrikant SrivastavaJohn Potokar
Jun 1, 1993·Cephalalgia : an International Journal of Headache·M D Ferrari, P R Saxena
Apr 29, 2006·The Journal of Pharmacology and Experimental Therapeutics·Dorota ZolkowskaMichael H Baumann
Nov 23, 2007·The Journal of Pharmacology and Experimental Therapeutics·Dorota ZolkowskaRichard B Rothman
Feb 1, 1992·Metabolism: Clinical and Experimental·I BlumO Raz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here